Literature DB >> 10068523

Protective effects of ulinastatin against ischemia-reperfusion injury.

Y Okuhama1, M Shiraishi, T Higa, H Tomori, K Taira, T Mamadi, Y Muto.   

Abstract

We investigated the protective effect of urinary trypsin inhibitor (ulinastatin: UTI) in vitro, in relation to the neutrophil activity in hepatic ischemia/reperfusion (I/R) injury. The rat liver was removed and preserved in cold Ringer's lactate solution for 60 min, followed by 120 min of reperfusion with oxygenated perfusate. The rats were divided into four groups (n = 8 in each group). The livers were perfused with Krebs-Henseleit (K-H) solution containing no additives in group 1, 50,000 U/kg of UTI in group 2, 3.5 x 10(6) of neutrophils in group 3, and both neutrophils and UTI in group 4. In group 3, the AST and ALT levels were always higher than those in other three groups at any point evaluated (P < 0.01) and the LDH levels were observed to be significantly higher than those in other three groups at 0, 5, 10, 60, and 90 min after reperfusion (P < 0. 01). These increase were suppressed by additional pretreatment with UTI in group 4. The bile flow during reperfusion was significantly suppressed in group 3 compared to that of group 4, at both 30 (P < 0. 01) and 60 (P < 0.05) min after reperfusion. The MPO activity after reperfusion in group 3 also significantly increased compared to other three groups (P < 0.01). These data thus suggest that UTI ameliorated the ischemia/reperfusion injury in vitro by inhibiting of neutrophil accumulation in the postischemic liver. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068523     DOI: 10.1006/jsre.1998.5496

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

Review 1.  Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control.

Authors:  Mahmoud Abu-Amara; Kurinchi Selvan Gurusamy; George Glantzounis; Barry Fuller; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

2.  Intravenous infusion of ulinastatin attenuates acute kidney injury after cold ischemia/reperfusion.

Authors:  Yunpeng Wang; Cheng Peng; Zheng Zhang; Jing Shi; Yingli Lin; Liangyou Gu; Xin Ma; Hongzhao Li
Journal:  Int Urol Nephrol       Date:  2019-07-22       Impact factor: 2.370

3.  Sivelestat sodium hydrate inhibits neutrophil migration to the vessel wall and suppresses hepatic ischemia-reperfusion injury.

Authors:  Seisho Sakai; Hidehiro Tajima; Tomoharu Miyashita; Shin-Ichi Nakanuma; Isamu Makino; Hironori Hayashi; Hisatoshi Nakagawara; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Hidehito Saito; Seiichi Munesue; Yasuhiko Yamamoto; Tetsuo Ohta
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

Review 4.  Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion.

Authors:  Mahmoud Abu-Amara; Kurinchi Gurusamy; Satoshi Hori; George Glantzounis; Barry Fuller; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

5.  High level expression of bikunin in Pichia pastoris by fusion of human serum albumin.

Authors:  Xing-Hua Gou; Yu-Ying Liu; Qi-Lei Chen; Jian-Jun Tang; Da-Yu Liu; Liang Zou; Xiao-Yong Wu; Wei Wang
Journal:  AMB Express       Date:  2012-02-29       Impact factor: 3.298

6.  Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.

Authors:  Bin Song; Qi Bian; Cheng Hao Shao; Gang Li; An An Liu; Wei Jing; Rui Liu; Yi-Jie Zhang; Ying-Qi Zhou; Xian-Gui Hu; Gang Jin
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Effects of ulinastatin administered at different time points on the pathological morphologies of the lung tissues of rats with hyperthermia.

Authors:  Zai-Sheng Qin; Pei Tian; Xia Wu; Hong-Mei Yu; Na Guo
Journal:  Exp Ther Med       Date:  2014-04-01       Impact factor: 2.447

8.  Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.

Authors:  Bo Xu; Kun-Ping Li; Fei Shen; Huan-Qing Xiao; Wen-Song Cai; Jiang-Lin Li; Qi-Cai Liu; Lin Jia
Journal:  Biomed Res Int       Date:  2013-04-23       Impact factor: 3.411

9.  Urinary Trypsin Inhibitor Ameliorates Seawater Immersion-Induced Intestinal Mucosa Injury via Antioxidation, Modulation of NF-κB Activity, and Its Related Cytokines in Rats with Open Abdominal Injury.

Authors:  Xing Jian Zhang; Ya Li Wang; Song Zhou; Xiaojun Xue; Qiang Liu; Wen Hua Zhang; Jun Zheng
Journal:  Gastroenterol Res Pract       Date:  2014-08-21       Impact factor: 2.260

10.  Effect of ulinastatin on paraquat-induced-oxidative stress in human type II alveolar epithelial cells.

Authors:  Xiao-Xiao Meng; Rui-Lan Wang; Shan Gao; Hui Xie; Jiu-Ting Tan; Yong-Bin Qian
Journal:  World J Emerg Med       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.